Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.
Ann Oncol
; 32(11): 1445-1447, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1427516
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Clinical Deterioration
/
COVID-19
/
Neoplasms
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Ann Oncol
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS